Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study
Gerrit M. Große(Medizinische Hochschule Hannover), Marcus Brinkmann(Essen University Hospital), Sven Poli(Hertie Institute for Clinical Brain Research), Christian Weimar(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Hans‐Christoph Diener(University of Birmingham), Georg Royl(University Hospital Schleswig-Holstein), Klaus Gröschel(Johannes Gutenberg University Mainz), Nils Kuklik(University of Duisburg-Essen), Dominik Michalski(University Hospital Leipzig), Karin Weißenborn(Medizinische Hochschule Hannover), Paul Sparenberg(Unfallkrankenhaus Berlin), Christoph Eschenfelder(Boehringer Ingelheim (Germany)), Andreas Stang(Boston University), Anika Hüsing(German Cancer Research Center), Darius G. Nabavi(Vivantes Klinikum)
Cited by 16
Related Papers
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|616